or Try an Advanced Search...

    Technical Analysis for CHRO - Chromocell Therapeutics Corporation

    Grade Last Price % Change Price Change
    F 0.92 2.79% 0.03
    CHRO closed down 0.43 percent on Monday, September 9, 2024, on 13 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Up
    Historical CHRO trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 2.79%
    Weak + Overbought Other 2.79%
    BB Squeeze Started Range Contraction 2.79%
    Overbought Stochastic Strength 2.79%
    Gapped Down Weakness 2.79%
    Shooting Star Candlestick Bearish 2.35%
    Lizard Bearish Bearish Day Trade Setup 2.35%
    Narrow Range Bar Range Contraction 2.35%
    Doji - Bearish? Reversal 2.35%
    Weak + Overbought Other 2.35%
    Older End-of-Day Signals for CHRO ...

       Recent Intraday Alerts

    Alert Time
    Reversed from Down about 3 hours ago
    20 DMA Support about 6 hours ago
    Rose Above Previous Day's High about 6 hours ago
    Rose Above 10 DMA about 6 hours ago
    Outside Day about 6 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CHRO Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound is CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as for the treatment of eye pain and neuropathic pain. The company was founded in 2002 and is based in Freehold, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Neuropathic Pain Erythromelalgia Sodium Channel Blockers

    Is CHRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 11 Wall Street Breakfast: The Week Ahead
    Aug 7 Chromocell announces stock repurchase plan
    Aug 7 Chromocell Announces Stock Repurchase Plan
    Jul 15 Chromocell to Participate in the Virtual Investor Lunch Break Series
    May 13 Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
    Mar 21 Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
    Mar 18 Chromocell appoints Frank Knuettel as CEO, removing interim status
    Mar 18 Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
    Mar 12 Sidoti Events, LLC's Virtual March Small-Cap Conference
    See more CHRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.0
    52 Week Low 0.59
    Average Volume 27,643
    200-Day Moving Average 0.00
    50-Day Moving Average 1.01
    20-Day Moving Average 0.85
    10-Day Moving Average 0.90
    Average True Range 0.11
    RSI (14) 46.81
    ADX 10.57
    +DI 17.88
    -DI 21.05
    Chandelier Exit (Long, 3 ATRs) 0.63
    Chandelier Exit (Short, 3 ATRs) 0.91
    Upper Bollinger Bands 0.97
    Lower Bollinger Band 0.74
    Percent B (%b) 0.68
    BandWidth 27.24
    MACD Line -0.02
    MACD Signal Line -0.04
    MACD Histogram 0.0211
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.98
    Resistance 3 (R3) 0.98 0.95 0.97
    Resistance 2 (R2) 0.95 0.93 0.95 0.96
    Resistance 1 (R1) 0.92 0.91 0.94 0.92 0.96
    Pivot Point 0.89 0.89 0.90 0.89 0.89
    Support 1 (S1) 0.87 0.87 0.88 0.87 0.83
    Support 2 (S2) 0.84 0.86 0.84 0.83
    Support 3 (S3) 0.81 0.84 0.82
    Support 4 (S4) 0.81